Earnings

Technology Macroeconomic Uncertainty Customer Spending Quarterly Results Analysts

Bristol Myers Squibb Reports Narrower Q1 Loss, Beats Revenue Expectations

Despite a challenging quarter with multi-billion dollar acquisitions, Bristol Myers Squibb's sales growth was driven by strong performances from Eliquis and new drugs.

10 ARTICLES

last yr.

IBM Acquires HashiCorp for $6.4 Billion to Bolster Cloud Infrastructure Management